Older adults are prescribed sedative-hypnotic medications at higher rates than younger adults. These are not recommended for older adults due to risk of sedation, cognitive impairment, and falls. Severe generalized anxiety disorder (GAD) is a possibly appropriate use of these medications in older people, but little is available on use of sedative-hypnotic medications among older adults with GAD. This study examined the frequency and predictors of sedative-hypnotic medication use among older adults screening positive for anxiety. 25.88% (n = 125) of participants reported taking sedative-hypnotics over the past 3 months; 16.36% (n = 79) reported taking benzodiazepines, and 12.22% (n = 59) reported taking hypnotic sleep medications. Depressive symptoms were more strongly associated with sedative-hypnotic use than insomnia or worry. Major depressive disorder and posttraumatic stress disorder, but not GAD, predicted sedative-hypnotic use. Other medications and treatments are more appropriate and efficacious for depression, anxiety, and insomnia in this population.
AlexopoulosG. S.KatzI. R.ReynoldsC. F.CarpenterD.DochertyJ. P.RossR. W. (2001) Pharmacotherapy of depression in older patients: A summary of the expert consensus guidelines. Journal of Psychiatric Practice7: 361–376. doi:10.1097/00131746-200111000-00003.
2.
AparasuR. R.MortJ. R. (2000) Inappropriate prescribing for the elderly: Beers criteria-based review. Annals of Pharmacotherapy34: 338–346. doi:10.1345/aph.19006.
3.
BaldwinD. S.PolkinghornC. (2005) Evidence-based pharmacotherapy of generalized anxiety disorder. The International Journal of Neuropsychopharmacology8: 293–302. doi:10.1017/S1461145704004870.
4.
BastienC. H.VallieresA.MorinC. M. (2001) Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Medicine2: 297–307. doi:10.1016/S1389-9457(00)00065-4.
5.
BergerA.MychaskiwM.DukesE.EdelsbergJ.OsterG. (2009) Magnitude of potentially inappropriate prescribing in Germany among older patients with generalized anxiety disorder. BMC Geriatrics9: 1–8. doi:10.1186/1471-2318-9-31.
6.
BertischS. M.HerzigS. J.WinkelmanJ. W.BuettnerC. (2014) National use of prescription medications for insomnia: NHANES 1999–2010. Sleep37: 343–349.
7.
CuijpersP.van StratenA.SmitF. (2006) Psychological treatment of late-life depression: A meta-analysis of randomized controlled trials. International Journal of Geriatric Psychiatry21: 1139–1149. doi:10.1002/gps.1620.
GlassJ.LanctôtK. L.HerrmannN.SprouleB. A.BustoU. E. (2005) Sedative hypnotics in older people with insomnia: Meta-analysis of risks and benefits. British Medical Journal331: 1169.doi:10.1136/bmj.38623.768588.47.
10.
GonçalvesD. C.ByrneG. J. (2012) Interventions for generalized anxiety disorder in older adults: Systematic review and meta-analysis. Journal of Anxiety Disorders26: 1–11. doi:10.1016/j.janxdis.2011.08.010.
11.
GouldR. L.CoulsonM. C.PatelN.Highton-WilliamsonE.HowardR. J. (2014) Interventions for reducing benzodiazepine use in older people: Meta-analysis of randomised controlled trials. The British Journal of Psychiatry204(2): 98–107. doi:10.1016/j.janxdis.2011.08.010107.
12.
HuangW. F.LaiI. C. (2006) Potentially inappropriate prescribing for insomnia in elderly outpatients in Taiwan. International Journal of Clinical Pharmacology and Therapeutics44: 335–342. doi:10.5414/CPP44335.
13.
KroenkeK.SpitzerR. L.WilliamsJ. B. (2001) The PHQ-9. Journal of General Internal Medicine16: 606–613. doi:10.1046/j.1525-1497.2001.016009606.x.
14.
KroenkeK.StrineT. W.SpitzerR. L.WilliamsJ. B.BerryJ. T.MokdadA. H. (2009) The PHQ-8 as a measure of current depression in the general population. Journal of Affective Disorders114: 163–173. doi:10.1016/j.jad.2008.06.026.
15.
LagnaouiR.DepontF.FourrierA.AbouelfathA.BegaudB.VerdouxH.MooreN. (2004) Patterns and correlates of benzodiazepine use in the French general population. European Journal of Clinical Pharmacology60: 523–529. doi:10.1007/s00228-004-0808-2.
16.
LeggettA.KavanaghJ.ZivinK.ChiangC.KimH. M.KalesH. C. (2015) The association between benzodiazepine use and depression outcomes in older veterans. Journal of Geriatric Psychiatry and Neurology28(4): 281–287. doi:10.1177/0891988715598227.
17.
MeyerT. J.MillerM. L.MetzgerR. L.BorkovecT. D. (1990) Development and validation of the Penn State Worry Questionnaire. Behaviour Research and Therapy28(6): 487–495. doi:10.1016/0005-7967(90)90135-6.
18.
MooreN.ParienteA.BégaudB. (2015) Why are benzodiazepines not yet controlled substances?JAMA Psychiatry72: 110–111. doi:10.1001/jamapsychiatry.2014.2190.
19.
MorinC. M.VallièresA.GuayB.IversH.SavardJ.MéretteC.BaillargeonL. (2009) Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: A randomized controlled trial. Journal of the American Medical Association301(19): 2005–2015. doi:10.1001/jama.2009.682.
20.
MorinC. M.WareJ. C. (1996) Sleep and psychopathology. Applied and Preventive Psychology5: 211–224. doi:10.1016/S0962-1849(96)80013-8.
21.
NeutelC. I.SkurtveitS.BergC. (2012) What is the point of guidelines? Benzodiazepine and z-hypnotic use by an elderly population. Sleep Medicine13: 893–897. doi:10.1016/j.sleep.2011.12.014.
22.
OlfsonM.KingM.SchoenbaumM. (2015) Benzodiazepine use in the United States. JAMA Psychiatry72: 136–142. doi:10.1001/jamapsychiatry.2014.1763.
23.
RadcliffS.YueJ.RoccoG.AielloS. E.IckowiczE.HurdZ.BeersM. H. (2015) American Geriatrics Society 2015 updated Beers criteria for potentially inappropriate medication use in older adults. Journal of the American Geriatric Society63: 2227–2246. doi:10.1111/jgs.13702.
24.
RazykovI.ZiegelsteinR. C.WhooleyM. A.ThombsB. D. (2012) The PHQ-9 versus the PHQ-8—is item 9 useful for assessing suicide risk in coronary artery disease patients? Data from the Heart and Soul Study. Journal of Psychosomatic Research73(3): 163–168. doi:10.1016/j.jpsychores.2012.06.001.
25.
SandelinR.KowalskiJ.AhnemarkE.AllgulanderC. (2013) Treatment patterns and costs in patients with generalised anxiety disorder: One-year retrospective analysis of data from national registers in Sweden. European Psychiatry28(2): 125–133. doi:10.1016/j.eurpsy.2012.02.003.
26.
SchuurmansJ.ComijsH. C.BeekmanA. T. F.BeursE. D.DeegD. J. H.EmmelkampP. M. G.DyckR. V. (2005) The outcome of anxiety disorders in older people at 6-year Follow-up: results from the Longitudinal Aging Study Amsterdam. Acta Psychiatrica Scandinavica111: 420–428. doi:10.1111/j.1600-0447.2005.00531.x.
27.
SegalD. L.CoolidgeF. L.CahillB. S.O'RileyA. A. (2008) Psychometric properties of the Beck Depression Inventory-II (BDI-II) among community-dwelling older adults. Behavior Modification32: 3–20. doi:10.1177/0145445507303833.
28.
StanleyM. A.WilsonN. L.AmspokerA. B.Kraus-SchumanC.WagenerP. D.CalleoJ. S.MasozeraN. (2014) Lay providers can deliver effective cognitive behavior therapy for older adults with generalized anxiety disorder: A randomized trial. Depression and Anxiety31: 391–401. doi:10.1002/da.22239.
29.
StanleyM. A.WilsonN. L.NovyD. M.RhoadesH. M.WagenerP. D.GreisingerA. J.KunikM. E. (2009) Cognitive behavior therapy for generalized anxiety disorder among older adults in primary care: A randomized clinical trial. Journal of the American Medical Association301(14): 1460–1467. doi:10.1001/jama.2009.458.
30.
TannenbaumC. (2015) Inappropriate benzodiazepine use in elderly patients and its reduction. Journal of Psychiatry & Neuroscience40(3): E27.doi:10.1503/jpn.140355.
31.
TannenbaumC.MartinP.TamblynR.BenedettiA.AhmedS. (2014) Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: The EMPOWER cluster randomized trial. JAMA Internal Medicine174(6): 890–898. doi:10.1001/jamainternmed.2014.949.
32.
WangP. S.BohnR. L.GlynnR. J.MogunH.AvornJ. (2001) Zolpidem use and hip fractures in older people. Journal of the American Geriatrics Society49(12): 1685–1690. doi:10.1111/j.1532-5415.2001.49280.x.
33.
WebbS. A.DiefenbachG.WagenerP.NovyD. M.KunikM.RhoadesH. M.StanleyM. A. (2008) Comparison of self-report measures for identifying late-life generalized anxiety in primary care. Journal of Geriatric Psychiatry and Neurology21: 223–231.
34.
WeichS.PearceH. L.CroftP.SinghS.CromeI.BashfordJ.FrisherM. (2014) Effect of anxiolytic and hypnotic drug prescriptions on mortality hazards: Retrospective cohort study. BMJ (Clinical Research Ed.)348,g1996–g1996.
35.
WetherellJ. L.GatzM.CraskeM. G. (2003) Treatment of generalized anxiety disorder in older adults. Journal of Consulting and Clinical Psychology71(1): 31–40. doi:10.1037/0022-006X.71.1.31.
